Michael Crawford


Visiting Professor, Imperial College,

Chelsea and Westminster Hospital Campus, London SW10 9NH, UK


Manahel Thabet





News Item: Just Published

In this paper we describe our discovery of a marker from the red cell membrane which is a powerful predictor for preterm delivery. Preterm delivery is a cardinal risk factor for developmental disorders of the brain.

As the red cell has a half life of 120 days this marker refers to the nutritional condition of the mother in the months before conception far more than events during the pregnancy itself. It held firm regardless of the mother having a supplement or not, regardless of her developing diabetes or hypertension!

That is it is her condition as she enters pregnancy which determines her vulnerability to adverse outcomes or a healthy baby.

Link: Peri-conception maternal lipid profiles predict pregnancy outcomes

Latest Videos

The latest videos, which can be found on YouTube, can be found in the video page [Video Page].

Alternatively, please click on the links below to vide the videos directly.

Link: Professor Michael Crawford Video for Wellohi

Link: So, you think you know Darwin? - David Marsh

Link: What is EPIGENETICS? Simon House

Link: Professor Michael Crawford - DHA

Link: Professor Michael Crawford - Omega 3 and DHA - the simple answer to improving mental health

Dr Manahel Thabet

Dr. Manahel Thabet received the Freedom of the City of London to honour her work in science, culture and education. Manahel is with Murray Craig the Clerk of the Chamberlain's Court who bestows the honour in a ceremony dating back to the 13th century.

Dr Manahel Thabet receiving the Freedom of the City of London from Murray Craig

goals of the institute

EU asked for an audit in 2004 about the cost of ill-health. Data described brain disorders at the cost of 386 billion Euros.  A cost surpassing all other burdens of ill-health. Lord Morris was persauded by us to ask the upper house the cost in the UK. Lord Warner did not know. To give credit, Dr. Jo Nurse for the Department of Health assessed the cost and reported it at £77 billion in 2007. A cost greater than combined expense of heart disease and cancer . Both were criticised as using new diagnostics. Even so, the cost above others was certainly significant. The cost for the EU was repeated in 2010 and found to be €789 billion. The UK repeat for 2010 came out at £105 billion. The Wellcome Trust had the cost for 2013 at £113 billion in 2013.

IBCHN explains this unacceptable rise, and offers the means to both prevent it and provide for continued enhancement of humanity.

The director's update

Click below to go to the Director's latest update.

Director's Update

Copyright © 2016 l All rights reserved.